Sensus Healthcare to Sponsor First International Keloid Symposium on September 8 and 9 in New York
BOCA RATON, Fla., Aug. 31, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), today announced that the Company will sponsor the First International Keloid Symposium to be held at The Rockefeller University […]
Ask Your Doctor About the SRT-100™ to Treat Your Basal Cell Carcinoma
Have you been diagnosed with skin cancer? You are not alone. Skin cancer is one of the most commonly occurring forms of cancer, with more than one in every three new cancers diagnosed as skin cancer. Basal cell carcinoma is one type of skin cancer and occurs more frequently than any other form of skin […]
Treat Your Patients’ Basal Cell Carcinoma with the Revolutionary SRT-100™
Any dermatologist knows just how devastating a skin cancer diagnosis can be to his or her patients. Skin cancer is diagnosed nearly three times as often as any other form of cancer, with the most common of all skin cancers being basal cell carcinoma. While patients facing basal cell carcinoma have multiple choices available for […]
Hear What Patients and Physicians Have to Say About the SRT-100™ for Keloid Treatment
Patients and physicians both are talking about revolutionary keloid treatment offered by the SRT-100™. Hear what they have to say. :
Sensus Healthcare Reports Second Quarter 2016 Results
– Q2 revenues increased 49% year-over-year to $3.6 million – Worldwide installed base increased to 247 units -Successfully completed IPO on June 2nd; cash of $15.8 million, with no debt, at June 30, 2016 BOCA RATON, Fla., Aug. 4, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of […]
Mike Masterson: Arkansas Approves Zapping Cancers
By Mike Masterson Posted: August 2, 2016 at 5:45 a.m. Editor’s note: The original version of the column was published March 9, 2014. There the thing still was, frowning from the mirror. That crusty red spot on the very tip of my nose wasn’t going away despite weeks of salves. It appeared to be steadily […]
Sensus Healthcare to Announce Second Quarter 2016 Results on August 4, 2016
BOCA RATON, Fla., Aug. 2, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS; SRTSW), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today provided a reminder that it will report its second quarter 2016 financial results on Thursday, August 4, 2016 […]
Sensus Healthcare, Inc. Names Anthony Petrelli to its Board of Directors
– Over 40 Years in Investment Banking – Extensive Regulatory and Securities Advisory Experience BOCA RATON, Fla., Aug. 2, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced the appointment of Anthony […]
New Procedure Spares Skin Cancer Patients From Surgery
Colorado’s Attorney General Cynthia Coffman became among the first in the state to undergo treatment with the SRT-100™. Doctor Kevin Schewe at Red Rocks Radiation Center, in partnership with Presbyterian/St. Luke’s Medical Center and Sarah Cannon Research Institute, is the only one in Colorado offering Superficial Radio Therapy with the SRT-100™ for patients with non-melanoma […]
